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reference showed a dose effect of alcohol on the HR of death: 2.36
(p = 0.052) for 1–29 g/day, 3.2 (p = 0.003) for 30–49 g/day, 3.51 (p <
0.0001) for 50–99 g/day and 5.61 (p < 0.0001) for ≥100 g/day. The
baseline MELD score was not predictive of long-term outcomewhile
Lille score (p = 0.02) and alcohol relapse (p < 0.0001) were inde-
pendent prognostic factors.
Conclusions: This study shows that new therapeutic development
for severe AH must target liver injury for short term and alcohol
consumption for long term. Thus, health agencies can endorse future
study design adapted to the time-frame of factors influencing
mortality. With this in mind, drugs targeting mechanisms involved
in liver injury should only be tested for the short-term period.
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Background and Aims: Alcohol consumption in China has substan-
tially increased over the last three decades and the number of
patients with alcoholic liver disease (ALD) is rising at an alarming
rate. However, accurate and representative data on time trends in its
hospitalization rates are not available. The aim of this study is to
assess the current status and burden of ALD in China byanalyzing the
data from a large tertiary referral hospital, Beijing 302 Hospital.
Methods: Data were retrospectively recorded from patients diag-
nosed as ALD in Beijing 302 Hospital from 2002 to 2013. The disease
spectrumand biochemical parameters of each patientwere collected.
Results: The patients with ALD accounted for 3.93% (7,422) of all
patients (188,902) with liver diseases between 2002 and 2013. The
numberof patients hospitalizedwith ALD increased from 110 in 2002
to 1,672 in 2013. The ratio of patients hospitalized with ALD to all
patients hospitalized with liver diseases was rising almost continu-
ously and increased from 1.68% in 2002 to 4.59% in 2013. Most
patients with ALD were male. Age distribution of ALD hospitalization
showed that the highest rate was in 40- to 49-year-old group in
subjects. Notably, the annual proportion of severe alcoholic hepatitis
(SAH) increased 2.43 times from 2002 to 2013. We found the
highest levels of MCV, the AST/ALT ratio, TBIL, INR, and ALP in SAH
patients, while serum levels of HGB, ALB, and CHEwere significantly
decreased in SAH group. Among these ALD, the SAH patient
population has the worst prognosis. Alcoholic cirrhosis (ALC) is the
most common ALD, and annual admissions for ALC increased
significantly during the analyzed period.
Conclusions: The number of hospitalized patients with ALD and the
annual hospitalization rate of ALD were increasing continuously in
Beijing 302 hospital from 2002 to 2013. More attention should be
paid to develop population-based effective strategy to control ALD.
Disclosure of Interest: None Declared.
FRI-301
MAIT cell dysfunctions correlate with markers of intestinal
integrity in ALD patients
A. Riva1,2, V. Patel3, K. Mehta1, C. Lopez3, G. Wright4, S. Tarff4,
A. Evans5, D. Shawcross6, J. Ryan6, R. Williams1,2, S. Chokshi1,2.
1Institute of Hepatology London, Foundation for Liver Research;
2Division of Transplantation, Immunology and Mucosal Biology, Faculty
of Life Sciences and Medicine, King’s College London; 3Department of
Biomedical Sciences, University of Westminster, London; 4Basildon and
Thurrock University Hospital, Basildon; 5Department of
Gastroenterology, Royal Berkshire Hospital, Reading; 6Institute of Liver
Sciences, King’s College London, London, United Kingdom
E-mail: a.riva@researchinliver.org.uk
Background and Aims: Mucosa-associated invariant T cells (MAIT)
reside in the gut, liver and systemic circulation and are a key
component of the host immunity. We have previously shown that the
immunocompromised state in ALD is associated with systemic
depletion of MAIT which display defective antibacterial responses
induced by contact with stool. Here we present new evidence
indicating thatMAITalterations correlate directly withmarkers of gut
mucosal integrity and bacterial translocation in ALD.
Methods:Wemeasured plasma levels of intestinal fatty acid binding
protein (FABP2) and D-lactate (DL), surrogate markers of mucosal
damage and live bacteria translocation, in ALD patients with alcohol
related cirrhosis (ARC, n = 9), alcohol abusers with varying degrees of
fibrosis (FibroScan) (AA, n = 35), severe alcoholic hepatitis (SAH, n =
12) and healthy controls (Ctrl, n = 13). We investigated correlations
with MAIT phenotype and functions (CD69/HLA-DR, PD1/TIM3/
LAG3, IFNγ/TNFα/IL17, CD107a/Perforin/GranzymeB) and clinical/
demographic information.
Results:DLwas significantly higher in ARC compared to controls (p =
0.001), even higher in patients with SAH (p < 0.001), and correlated
withmarkers of disease severity across groups (Child-Pugh: r = 0.601,
p = 0.008; MELD score: r = 0.750, p < 0.001). Interestingly, in AA
patients DL also correlated with CAP scores (Controlled Attenuation
Parameter, surrogate marker of liver steatosis: r = 0.372, p = 0.030).
DL levels were associated with MAIT activation (CD69: r = 0.686, p =
0.007) and hyperexpression of immunoinhibitory receptors (PD1: r =
0.595, p = 0.032; LAG3: r = 0.608, p = 0.028) in patients overall.
Further to this, in SAH patients DL correlated with cytotoxic potential
of MAIT (r = 0.985, p = 0.015). FABP2was comparable overall between
ALD and controls but patients had significantly higher variability (p <
0.025). Within the ARC group, 4 subjects had strongly elevated FABP2
(p = 0.014) and in this group MAIT were similar to those seen in SAH,
with altered activation levels (p = 0.031), hyperexpression of
immune-inhibitory receptor LAG3 (p = 0.021) and more cytotoxic
(p = 0.021).
Conclusions: In conclusion, increased intestinal mucosal damage
and bacterial translocation seem to discriminate between ARC and
SAH patients and are directly associated with alteredMAITcells, with
activation/inhibition imbalance but enhanced cytotoxic capacity,
suggesting they may be driving inflammation, immune mediated
tissue damage and susceptibility to bacterial infection in ALD.
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Background and Aims: There remains much uncertainty in the
optimal management of patients with acute severe alcoholic
hepatitis (SAH). Recent evidence from the STOPAH clinical trial
suggests a modest short-term survival benefit with corticosteroid
treatment but a significantly increased risk of mortality with
infection prompting clinicians to use corticosteroids more cautiously.
We aimed to document the current variation in clinical management
of these patients in the UK and determine whether the results of the
STOPAH trial have changed practice.
Methods: An anonymised online survey of gastroenterologists,
hepatologists and trainees in the UK was conducted which
was distributed via the British Association for the Study of the Liver
and the British Society of Gastroenterology. Data was analysed
descriptively.
Results: There were 129 respondents including 52 hepatologists,
23 gastroenterologists with an interest in hepatology and 33
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trainees/fellows. 36% worked in acute hospitals with level 2
hepatology services, 22% in hospitals with hepatology services, 20%
in district general hospitals and 22% in transplant centres.
Corticosteroids remain the most common pharmacological therapy
either used alone (72%) or in combinationwith pentoxifylline (3%) or
N-acetylcisteine (8%). No pharmacological therapy was used in 16%.
The majority (74%) intended to complete 28 days of treatment with
corticosteroid but 92% applied steroid discontinuation rules either
based on the Lille score (40%), early change in bilirubin (23%) or a
combination of other factors (37%). 76% felt that the STOPAH trial had
altered their practice either by changing their choice of treatment
(68%) or by discontinuing corticosteroids in patients with infection
(26%). However, no respondent was satisfied with the current
management options for SAH and suggested clinical trials of novel
therapy (73%), improved access to alcohol liaison services (57%),
development of an updated clinical guideline (51%) and improved
methods to determine corticosteroid responsiveness (48%) as
strategies to improve care.
Conclusions: Corticosteroids remain the most popular pharmaco-
logical therapy for SAH. However, there iswide variation in practice in
the UK regarding length of treatment course and discontinuation
rules reflecting the uncertainty of how to measure clinical cortico-
steroid response. There is a need to improve methods of patient
stratification to enable accurate selection of patients who derive the
most benefit from corticosteroids.
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Background and Aims: Monocytes respond to pathogenic and
inflammatory signals to coordinate the immune response. They are
important in acute severe alcoholic hepatitis (AAH) in which
infection often contributes to severe liver inflammation. Three
phenotypically distinct monocyte subsets have been described:
classical (CD14++CD16−), intermediate (CD14++CD16+) and non-
classical (CD14+CD16++). Enrichment of intermediate monocytes
has been demonstrated in many inflammatory conditions which we
have previously confirmed in AAH. However, their functional
phenotype has not been fully characterised. We aimed to investigate
monocyte subset function in terms of phagocytosis, monocyte
oxidative burst (MOB) and T cell interaction in patients with AAH in
comparison to healthy controls (HC).
Methods: Peripheral blood mononuclear cells were isolated from
10 patients with AAH (recent onset jaundice in a heavy alcohol
drinker; DF > 32; AST:ALT > 1.5) and 6 HCs. Monocyte subsets and
memory CD4+ T cells were isolated by flow cytometry. MOB was
determined by oxidation of dihydrorhodamine to rhodamine123
over 10 minutes which was quantified in each subset by flow
cytometry. Phagocytosis was determined by cellular uptake of
fluorescent latex beads. Memory CD4+ T cells were co-cultured for 5
days with eachmonocyte subset and Tcell phenotype determined by
flow cytometry.
Results: Intermediate monocytes are expanded in patients with AAH
compared to HCs (24% v 9%; p < 0.001). Phagocytic capacity of
classical and intermediate monocytes from patients with AAH was
similar and significantly greater than HCs (62% v 44% for classical; p =
0.02 and 59% v 20% for intermediate; p < 0.001). MOB was similar
between classical and intermediate monocytes from AAH patients
(62% and 56% rhodamine123 positive respectively). Memory T cell
proliferationwas greater in co-cultures with intermediatemonocytes
from AAH patients than HCs (73% v 50%; p = 0.03) but proliferation,
IL-17 and IFNγ expression were similar in co-cultures with each
monocyte subset in patients with AAH.
Conclusions: Intermediate monocytes are functionally activated
with higher capacity for phagocytosis and ability to drive T cell
proliferation in AAH patients than in HCs. In patients with AAH
classical and intermediate monocyte subsets have a similar func-
tional phenotype. These in vitro surrogates of monocyte function
suggest that in the context of severe inflammation the expanded pool
of circulating intermediate monocytes is primed to clear pathogens
and perpetuate the immune response.
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Background and Aims: Malnutrition is a major concern in alcoholic
cirrhosis (AC) which needs urgent attention. Prevalence of malnutri-
tion varies with themethods used for assessment. Gamut of methods
ranging from traditional like anthropometry, functional status and
composite scores, to reference methods like bioelectrical impedance
analysis and radiological imaging are available for defining malnu-
trition. Aims: To assess nutritional status of patients with AC using
various methods.
Methods: 147 consecutive pts with AC, from Jun 2013 to Aug 2015
underwent complete nutritional workup using anthropometry
[triceps skin fold (TSF) by Harpenden’s calliper;mid arm muscle
circumference (MAMC)] hand grip strength (HSG) by electronic
dynamometer, Royal Free Hospital-Subjective Global Assessment
(RFH-SGA), Phase angle (PA) by multifrequency TANITA & skeletal
muscle index (SMI) by single slice L3 CT image by Slice-Omatic
software. Dietary intake using 24 hr dietary recall along with semi-
quantitative food frequency method. Energy requirements (ER)were
estimated using Harris Benedict equation.Protein requirements (PR)
were assessed as 1.2 gm/Kg IBW. Demographic, clinical, and bio-
chemical data were also collected. The cut-offs for defining
malnutrition by TSF (12.5 mm), MAMC (24.5 cm), HGS (37.5 Kg), PA
(5.4°) were taken from literaturewhile that of SMI (36.5 cm2/m2) was
from our own ethnic data of healthy controls (2SD below the mean;
unpublished data)
Results: In total 147 AC[M-100%; age- 44.08 ± 9; BMI- 18.45 ± 6.85;
Child A:B:C-14%:38%:48%, disease duration 8 (1–40 mo), alcohol
intake 112 ± 30 gm] were studied. Mean intake of proximate
principles was calorie 1,588.94 ± 566.68 Kcal (69.6% of EER), protein
57.6 ± 25.2 (73% of PR)carbohydrates 263.3 ± 20, fat 32.7 ± 4.2;
erroneous dietary restrictions were practiced by 91.5% patients.
Mean values of TSF, MAMC, HGS, PA, and SMI were11.73 ± 5.52 mm;
21.38 ± 2.8 cm; 25.37 ± 6.98 Kg; 4.97 ± 1.3°; and 46.2 ± 10.4 cm2/m
viz. Prevalence of malnutrition as n (%) was: TSF-92 (62.6%); MAMC-
137 (93.2%); HG-141 (95.9%); RFH-SGA-123 (83.6%), PA-102 (69.4%)
and SMI-23 (15.6%).
Conclusions: Prevalence of malnutrition and dietary inadequacy is
high in patients with ALD; however nutritional assessment tools
do not uniformly identify patients as malnourished. Traditional as
well as modern methods (TSF, MAMC, RFH-SGA, and PA) using
western cut-offs may overestimate malnutrition while the reference
method (SMI) using ethnic cut-offs challenge these values. Hence
there is an urgent need for ethnic cut-offs for all methods to obtain
uniformity.
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